scholarly article | Q13442814 |
review article | Q7318358 |
P50 | author | Daniela P Freitas | Q59674935 |
Ana Magalhães | Q82158704 | ||
Henrique O Duarte | Q87886034 | ||
Celso A. Reis | Q37831414 | ||
P2093 | author name string | Joana Gomes | |
Catarina Gomes | |||
P2860 | cites work | Terminal alpha1,4-linked N-acetylglucosamine in Helicobacter pylori-associated intestinal metaplasia of the human stomach and gastric carcinoma cell lines | Q40291475 |
Expression of Lea in gastric cancer cell lines depends on FUT3 expression regulated by promoter methylation | Q40326698 | ||
Thomsen-Friedenreich antigen expression in gastric carcinomas is associated with MUC1 mucin VNTR polymorphism. | Q40480034 | ||
Role of the human ST6GalNAc-I and ST6GalNAc-II in the synthesis of the cancer-associated sialyl-Tn antigen | Q40507967 | ||
Natural antibiotic function of a human gastric mucin against Helicobacter pylori infection. | Q40525525 | ||
CDX2 homeoprotein is involved in the regulation of ST6GalNAc-I gene in intestinal metaplasia. | Q41081633 | ||
CD44: structure, function, and association with the malignant process. | Q41438683 | ||
Loss of Differentiation in Intestinal Metaplasia in Cancerous Stomachs.A Comparative Morphologic Study | Q41704526 | ||
Fut2-null mice display an altered glycosylation profile and impaired BabA-mediated Helicobacter pylori adhesion to gastric mucosa | Q42015583 | ||
Helicobacter pylori CagA protein targets the c-Met receptor and enhances the motogenic response | Q42064313 | ||
Peripheral alpha-linked N-acetylglucosamine on the carbohydrate moiety of mucin derived from mammalian gastric gland mucous cells: epitope recognized by a newly characterized monoclonal antibody | Q42086138 | ||
Regulation of Helicobacter pylori adherence by gene conversion | Q42187297 | ||
Role of fucosyltransferases in the association between apomucin and Lewis antigen expression in normal and malignant gastric epithelium | Q42274023 | ||
Expression pattern of polypeptide N-acetylgalactosaminyltransferase-10 in gastric carcinoma | Q42417033 | ||
Reciprocal Modulation of Terminal Sialylation and Bisecting N-Glycans: A New Axis of Cancer-Cell Glycome Regulation? | Q42911192 | ||
Human trefoil factor 2 is a lectin that binds α-GlcNAc-capped mucin glycans with antibiotic activity against Helicobacter pylori. | Q42926733 | ||
Expression of UDP-N-acetyl-D-galactosamine: polypeptide N-acetylgalactosaminyltransferase-6 in gastric mucosa, intestinal metaplasia, and gastric carcinoma. | Q43225298 | ||
Dimeric sialyl-Le(x) expression in gastric carcinoma correlates with venous invasion and poor outcome | Q43512005 | ||
Polymorphisms of two fucosyltransferase genes (Lewis and Secretor genes) involving type I Lewis antigens are associated with the presence of anti-Helicobacter pylori IgG antibody. | Q43727854 | ||
The clinical significance of sialyl Lewis antigen expression in the spread of gastric cancer. Flow cytometric DNA analysis | Q44425750 | ||
Simple mucin-type carbohydrate antigens (Tn, sialosyl-Tn and T) in gastric mucosa, carcinomas and metastases | Q44568970 | ||
Close correlation between increased sialyl-Lewisx expression and metastasis in human gastric carcinoma | Q45102566 | ||
Infection by Helicobacter pylori expressing the BabA adhesin is influenced by the secretor phenotype | Q46580526 | ||
Expression of fully and under-glycosylated forms of MUC1 mucin in gastric carcinoma. | Q47705298 | ||
The expression pattern of UDP-N-acetyl-alpha-d-galactosamine: polypeptide N-acetylgalactosaminyl transferase-3 in early gastric carcinoma | Q47867942 | ||
A family of UDP-GalNAc: polypeptide N-acetylgalactosaminyl-transferases control the initiation of mucin-type O-linked glycosylation | Q48060342 | ||
Aberrant expression of human mucin gene MUC5B in gastric carcinoma and cancer cells. Identification and regulation of a distal promoter | Q48373208 | ||
Intestinal metaplasia with colonic-type sulphomucins in the gastric mucosa; its association with gastric carcinoma. | Q50943375 | ||
Glycoengineered cell models for the characterization of cancer O-glycoproteome: an innovative strategy for biomarker discovery. | Q50961166 | ||
ST6GalNAc-I controls expression of sialyl-Tn antigen in gastrointestinal tissues. | Q51767552 | ||
CDw75 antigen expression in human gastric carcinoma and adjacent mucosa. | Q53478477 | ||
Lewis system alterations in gastric carcinogenesis. | Q53504569 | ||
Genetic activation of the MET pathway and prognosis of patients with high-risk, radically resected gastric cancer. | Q54341358 | ||
Altered mRNA expressions of sialyltransferases in human gastric cancer tissues. | Q54398386 | ||
Management of precancerous conditions and lesions in the stomach (MAPS): guideline from the European Society of Gastrointestinal Endoscopy (ESGE), European Helicobacter Study Group (EHSG), European Society of Pathology (ESP), and the Sociedade Portug | Q57698678 | ||
Influence of the amino acid sequence on the MUC5AC motif peptide O-glycosylation by human gastric UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase(s) | Q58160867 | ||
Intestinal metaplasia of human stomach displays distinct patterns of mucin (MUC1, MUC2, MUC5AC, and MUC6) expression | Q59182772 | ||
T (Thomsen?Friedenreich) antigen and other simple mucin-type carbohydrate antigens in precursor lesions of gastric carcinoma | Q59182870 | ||
Helicobacter pylori cagpathogenicity island-positive strains induce syndecan-4 expression in gastric epithelial cells | Q59892803 | ||
The LacdiNAc-Specific Adhesin LabA Mediates Adhesion of Helicobacter pylori to Human Gastric Mucosa | Q60403350 | ||
Expression of mucins (MUC1, MUC2, MUC5AC, and MUC6) and type 1 Lewis antigens in cases with and withoutHelicobacter pyloricolonization in metaplastic glands of the human stomach | Q60444903 | ||
Substrate specificities of three members of the human UDP-N-acetyl-alpha-D-galactosamine:Polypeptide N-acetylgalactosaminyltransferase family, GalNAc-T1, -T2, and -T3 | Q24311744 | ||
Characterization of a novel human UDP-GalNAc transferase, pp-GalNAc-T10 | Q24315839 | ||
Mucins in cancer: function, prognosis and therapy | Q24633765 | ||
Helicobacter pylori SabA adhesin in persistent infection and chronic inflammation | Q24650188 | ||
Polymorphisms in mucin genes in the development of gastric cancer | Q26776186 | ||
Clinical significance of MET in gastric cancer | Q26776190 | ||
Control of mucin-type O-glycosylation: a classification of the polypeptide GalNAc-transferase gene family | Q26864268 | ||
Targeting receptor tyrosine kinases in gastric cancer | Q27013050 | ||
Interactions between Hyaluronan and Its Receptors (CD44, RHAMM) Regulate the Activities of Inflammation and Cancer | Q27021261 | ||
Prognostic significance of MET amplification and expression in gastric cancer: a systematic review with meta-analysis | Q27027981 | ||
The Three-dimensional Structure of the Extracellular Adhesion Domain of the Sialic Acid-binding Adhesin SabA fromHelicobacter pylori | Q27681123 | ||
Cloning of a human UDP-N-acetyl-alpha-D-Galactosamine:polypeptide N-acetylgalactosaminyltransferase that complements other GalNAc-transferases in complete O-glycosylation of the MUC1 tandem repeat | Q28118379 | ||
CD44 in cancer | Q28217782 | ||
Mucins in cancer: protection and control of the cell surface | Q28235006 | ||
CD44 is the principal cell surface receptor for hyaluronate | Q28261336 | ||
Management of Helicobacter pylori infection--the Maastricht IV/ Florence Consensus Report | Q28264077 | ||
Functional adaptation of BabA, the H. pylori ABO blood group antigen binding adhesin | Q28273716 | ||
Global eradication rates for Helicobacter pylori infection: systematic review and meta-analysis of sequential therapy | Q28296156 | ||
Glycomic and sialoproteomic data of gastric carcinoma cells overexpressing ST3GAL4. | Q31076830 | ||
Expression of ST3GAL4 leads to SLe(x) expression and induces c-Met activation and an invasive phenotype in gastric carcinoma cells | Q31121236 | ||
Identification of common and unique peptide substrate preferences for the UDP-GalNAc:polypeptide alpha-N-acetylgalactosaminyltransferases T1 and T2 derived from oriented random peptide substrates | Q33254101 | ||
SabA is the H. pylori hemagglutinin and is polymorphic in binding to sialylated glycans | Q33264403 | ||
Role of ABO secretor status in mucosal innate immunity and H. pylori infection | Q33313489 | ||
Pathobiology of Helicobacter pylori-Induced Gastric Cancer | Q33361550 | ||
Comparative genomics of Helicobacter pylori: analysis of the outer membrane protein families | Q33597903 | ||
Polypeptide N-acetylgalactosaminyltransferase 2 regulates cellular metastasis-associated behavior in gastric cancer | Q33703870 | ||
Molecular studies into the role of CD44 variants in metastasis in gastric cancer | Q33706667 | ||
The structure and assembly of secreted mucins | Q33763293 | ||
MUC1 and cancer | Q33778447 | ||
Tyrosine kinases and gastric cancer | Q34103663 | ||
Polypeptide GalNAc-transferases, ST6GalNAc-transferase I, and ST3Gal-transferase I expression in gastric carcinoma cell lines. | Q34198013 | ||
Clinical relevance of sialyltransferases ST6GAL-I and ST3GAL-III in gastric cancer | Q34224371 | ||
Precancerous lesions in the stomach: from biology to clinical patient management. | Q34354090 | ||
Regulation of mucin and glycoconjugate expression: from normal epithelium to gastric tumors | Q34386340 | ||
Expression of CD44 and its variants on gastric epithelial cells of patients with Helicobacter pylori colonisation | Q34409537 | ||
Signaling properties of hyaluronan receptors | Q34444928 | ||
Helicobacter pylori adhesin binding fucosylated histo-blood group antigens revealed by retagging | Q34452414 | ||
Translocation of Helicobacter pylori CagA into gastric epithelial cells by type IV secretion | Q34507324 | ||
Glycoproteomic analysis of serum from patients with gastric precancerous lesions | Q34546096 | ||
Protein glycosylation in cancer | Q35413473 | ||
CD44 plays a functional role in Helicobacter pylori-induced epithelial cell proliferation. | Q35556818 | ||
Human gastric carcinogenesis: a multistep and multifactorial process--First American Cancer Society Award Lecture on Cancer Epidemiology and Prevention | Q35570715 | ||
Life at the margins: modulation of attachment proteins in Helicobacter pylori | Q35577892 | ||
Probing the O-glycoproteome of gastric cancer cell lines for biomarker discovery. | Q35692128 | ||
Helicobacter pylori outer membrane proteins and gastroduodenal disease | Q35760550 | ||
CD44 is required for two consecutive steps in HGF/c-Met signaling. | Q35805198 | ||
Association Between Helicobacter pylori Eradication and Gastric Cancer Incidence: A Systematic Review and Meta-analysis. | Q35912196 | ||
MET in gastric carcinomas: comparison between protein expression and gene copy number and impact on clinical outcome | Q36089948 | ||
Helicobacter pylori chronic infection and mucosal inflammation switches the human gastric glycosylation pathways | Q36263451 | ||
Porcine submaxillary gland apomucin contains tandemly repeated, identical sequences of 81 residues. | Q36298649 | ||
Interaction of CagA with Crk plays an important role in Helicobacter pylori-induced loss of gastric epithelial cell adhesion | Q36403673 | ||
Clinical relevance of the Helicobacter pylori gene for blood-group antigen-binding adhesin | Q36556507 | ||
Clinicopathologic significance of sialyl Le(x) expression in advanced gastric carcinoma | Q36621614 | ||
Helicobacter pylori induces beta3GnT5 in human gastric cell lines, modulating expression of the SabA ligand sialyl-Lewis x | Q36655027 | ||
Structural Insights into Polymorphic ABO Glycan Binding by Helicobacter pylori | Q36690768 | ||
MUC6 apomucin shows a distinct normal tissue distribution that correlates with Lewis antigen expression in the human stomach | Q36692591 | ||
MUC1-C oncoprotein as a target in breast cancer: activation of signaling pathways and therapeutic approaches | Q36753508 | ||
Deregulation of MUC4 in gastric adenocarcinoma: potential pathobiological implication in poorly differentiated non-signet ring cell type gastric cancer | Q36882675 | ||
Carcinogenesis of Helicobacter pylori | Q36903152 | ||
MET amplification as a potential therapeutic target in gastric cancer. | Q36984821 | ||
Mucin glycosylating enzyme GALNT2 suppresses malignancy in gastric adenocarcinoma by reducing MET phosphorylation | Q36998213 | ||
Polypeptide N-acetylgalactosaminyl transferase 3 independently predicts high-grade tumours and poor prognosis in patients with renal cell carcinomas. | Q37040588 | ||
HER2 in gastric cancer: a new prognostic factor and a novel therapeutic target | Q37149210 | ||
Relevance of MUC1 mucin variable number of tandem repeats polymorphism in H pylori adhesion to gastric epithelial cells. | Q37220689 | ||
A subset of gastric cancers with EGFR amplification and overexpression respond to cetuximab therapy | Q37240838 | ||
Expression of the Helicobacter pylori adhesin SabA is controlled via phase variation and the ArsRS signal transduction system | Q37274259 | ||
Lewis antigen alterations in gastric cancer precursors | Q67732513 | ||
Expression of Blood Group-Related Antigens, ABH, Lewisa, Lewisb, Lewisx, Lewisy, CA19-9, and CSLEX1 in Early Cancer, Intestinal Metaplasia, and Uninvolved Mucosa of the Stomach | Q68179534 | ||
Subunit structure of porcine submaxillary mucin | Q69718472 | ||
Expression of Lewisa, Lewisb, Lewisx, Lewisy, siayl-Lewisa, and sialyl-Lewisx blood group antigens in human gastric carcinoma and in normal gastric tissue | Q69936076 | ||
Lewis blood group-related antigen expression in normal gastric epithelium, intestinal metaplasia, gastric adenoma, and gastric carcinoma | Q70740933 | ||
The mucin profiles of normal gastric mucosa, intestinal metaplasia and its variants and gastric carcinoma | Q71097848 | ||
Prognostic significance of T antigen expression in patients with gastric carcinoma | Q71116832 | ||
T and Tn, general carcinoma autoantigens | Q71372455 | ||
Schistosomes, liver flukes and Helicobacter pylori. IARC Working Group on the Evaluation of Carcinogenic Risks to Humans. Lyon, 7-14 June 1994 | Q72152032 | ||
Mucin gene expression in normal, preneoplastic, and neoplastic human gastric epithelium | Q72312433 | ||
Fucosyltransferase-producing sialyl Le(a) and sialyl Le(x) carbohydrate antigen in benign and malignant gastrointestinal mucosa | Q72674365 | ||
Immunohistochemical study of MUC5AC expression in human gastric carcinomas using a novel monoclonal antibody | Q73081862 | ||
Immunohistochemical study of the expression of MUC6 mucin and co-expression of other secreted mucins (MUC5AC and MUC2) in human gastric carcinomas | Q73462707 | ||
Histopathological subtypes and prognosis of gastric cancer are correlated with the expression of mucin-associated sialylated antigens: Sialosyl-Lewis(a), Sialosyl-Lewis(x) and sialosyl-Tn | Q77564890 | ||
Expression of MUC1 and MUC2 mucins in gastric carcinomas: its relationship with the prognosis of the patients | Q77603489 | ||
Helicobacter pylori infection produces reversible glycosylation changes to gastric mucins | Q77669427 | ||
The aberrant expression of Lewis a antigen in intestinal metaplastic cells of gastric mucosa is caused by augmentation of Lewis enzyme expression | Q77740638 | ||
Mucins MUC1, MUC2, MUC5AC and MUC6 expression in the evaluation of differentiation and clinico-biological behaviour of gastric carcinoma | Q77755083 | ||
Disseminated cancer cells in the blood and expression of sialylated antigen in gastric cancer | Q79150076 | ||
Sweet receptors mediate the adhesion of the gastric pathogen Helicobacter pylori: glycoproteomic strategies | Q84381610 | ||
Synthesis of bivalent glycoclusters containing GlcNAc as hexasaccharide mimetics. Bactericidal activity against Helicobacter pylori | Q84969930 | ||
Helicobacter pylori | Q85652456 | ||
Role of sulfated O-glycans expressed by high endothelial venule-like vessels in pathogenesis of chronic inflammatory gastrointestinal diseases | Q37283590 | ||
Alpha1,4GlcNAc-capped mucin-type O-glycan inhibits cholesterol alpha-glucosyltransferase from Helicobacter pylori and suppresses H. pylori growth. | Q37378007 | ||
The engagement of selectins and their ligands in colorectal cancer liver metastases | Q37559776 | ||
Clinical significance of polypeptide N-acetylgalactosaminyl transferase-5 (GalNAc-T5) expression in patients with gastric cancer | Q37711697 | ||
Alterations in glycosylation as biomarkers for cancer detection | Q37721665 | ||
Selectins promote tumor metastasis. | Q37746080 | ||
Helicobacter pylori: gastric cancer and beyond | Q37760037 | ||
MSP-RON signalling in cancer: pathogenesis and therapeutic potential | Q38116308 | ||
Mucins in pancreatic cancer and its microenvironment | Q38121746 | ||
Gastric cancer: adding glycosylation to the equation | Q38128077 | ||
Attachment of Helicobacter pylori to human gastric epithelium mediated by blood group antigens | Q38313312 | ||
Structural diversity and specific distribution of O-glycans in normal human mucins along the intestinal tract | Q38336832 | ||
Glycosylation in cancer: mechanisms and clinical implications | Q38569702 | ||
Bacteria-targeted biomaterials: Glycan-coated microspheres to bind Helicobacter pylori. | Q38799885 | ||
Glycomic analysis of gastric carcinoma cells discloses glycans as modulators of RON receptor tyrosine kinase activation in cancer | Q38807457 | ||
Bacterial-binding chitosan microspheres for gastric infection treatment and prevention | Q39114565 | ||
A human model of gastric carcinogenesis. | Q39644851 | ||
De novo expression of CD44 variants in sporadic and hereditary gastric cancer | Q39653487 | ||
Differential expression of alpha-2,3-sialyltransferases and alpha-1,3/4-fucosyltransferases regulates the levels of sialyl Lewis a and sialyl Lewis x in gastrointestinal carcinoma cells. | Q39795184 | ||
CagA associates with c-Met, E-cadherin, and p120-catenin in a multiproteic complex that suppresses Helicobacter pylori-induced cell-invasive phenotype | Q39825147 | ||
Mucous glycoproteins: a gel of a problem | Q39827428 | ||
Identification of gastric cancer stem cells using the cell surface marker CD44. | Q39856772 | ||
MUC2 mucin is a major carrier of the cancer-associated sialyl-Tn antigen in intestinal metaplasia and gastric carcinomas. | Q39940364 | ||
Helicobacter pylori induces gastric epithelial cell invasion in a c-Met and type IV secretion system-dependent manner | Q40228842 | ||
Biological significance of cancer-associated sialyl-Tn antigen: modulation of malignant phenotype in gastric carcinoma cells. | Q40233254 | ||
P275 | copyright license | Creative Commons Attribution | Q6905323 |
P6216 | copyright status | copyrighted | Q50423863 |
P433 | issue | 3 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | stomach neoplasm | Q4335552 |
mucin | Q410862 | ||
glycosylation | Q898365 | ||
carcinogenesis | Q1637543 | ||
P5008 | on focus list of Wikimedia project | ScienceSource | Q55439927 |
P577 | publication date | 2016-07-11 | |
P1433 | published in | Biomolecules | Q23929963 |
P1476 | title | Mucin-Type O-Glycosylation in Gastric Carcinogenesis | |
P478 | volume | 6 |
Q89475533 | C1GALT1 is associated with poor survival and promotes soluble Ephrin A1-mediated cell migration through activation of EPHA2 in gastric cancer |
Q90589038 | Deficiency in the glycosyltransferase Gcnt1 increases susceptibility to tuberculosis through a mechanism involving neutrophils |
Q49185043 | Drug resistance related to aberrant glycosylation in colorectal cancer |
Q92063533 | Esophageal, gastric and colorectal cancers: Looking beyond classical serological biomarkers towards glycoproteomics-assisted precision oncology |
Q60949584 | Functional Roles of -Glycosylation |
Q55517393 | GalNAc-T15 in gastric adenocarcinoma: Characterization according to tissue architecture and cellular location. |
Q90240459 | The structure of the colorectal cancer-associated enzyme GalNAc-T12 reveals how nonconserved residues dictate its function |
Search more.